Contribution of 99mtc-anti-carcinoembryonic antigen antibody and 99mtc-sestamibi scintimammography in the evaluation of high risk palpable breast lesions

Nuclear Medicine Communications

Volumn 24, Issue 3, 2003, Pages 291-296

  Sanidas, E E ^a   Koukouraki, S ^a   Velidaki, A ^a   Manios, A ^a   Stathopoulos, E ^b   DE BREE, E ^b   Kafousi, M ^b   Kodogiannis, E ^b   Karkavitsas, N ^b   Tsiftsis, D D ^b  

^a Nuclear Medicine   (United States)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Arcitumomab; Monoclonal antibody; Scintimammography; Sestamibi

Indexed keywords

99MTC ANTI CARCINOEMBRYONIC ANTIGEN ANTIBODY; 99MTC-ANTI-CARCINOEMBRYONIC ANTIGEN ANTIBODY; DIAGNOSTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MIDDLE AGED; NEOPLASM STAGING; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0141430922     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200303000-00009     Document Type: Article

References (19)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5-27.
2. Symmonds R, Roberts JW. Management of nonpalpable breast abnormalities. Ann Surg 1987; 205: 520-524.
3. Tresadern JC, Asbury D, Hartley G, Sellwood RA, Borg-Grech A, Watson RJ. Fine wire localization and biopsy of non-palpable breast lesions. Br J Surg 1990; 77: 320-322.
4. Jackson VP, Hendrick RE, Feig SA, Kopans DB. Imaging of the radiologically dense breasts. Radiology 1993; 188: 297-301.
5. Cady B. Breast cancer in the third millennium (Editorial). J Clin Oncol 2001; 77: 225-232.
6. Goldenberg DM, Larson SM. Radioimmunodetection in cancer identification. J Nucl Med 1992; 33: 803-814.
7. Hughes K, Pinsky C, Petrelli N, et al. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. Ann Surg 1997; 226: 621-631.
8. Goldenberg DM, Kim E, DeLand F, Bennett S, Primus FJ. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980; 40: 2984-2992.
9. Goldenberg DM, Abdel-Nabi H, Sullivan C, et al. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma. Cancer 2000; 89: 104-115.
10. O'Higgins N, Linos DA, Blichert-Toft M, et al. European guidelines for quality assurance in the surgical management of mammographically detected lesions. Eur J Surg Oncol 1998; 24: 96-98.
11. Koukouraki S, Koukourakis MI, Vagios E, Velidaki A, Tsiftsis D, Karkavitsas N. The role of 99mTc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions. Nucl Med Commun 2001; 22: 1243-1248.
12. Coveney EC, Geraaghty JG, O'Laoide R, Hourihane JB, O'Higgins NJ. Reasons underlying negative mammography in patients with palpable breast cancer. Clin Radiol 1994; 49: 123-125.
13. Scott S, Morrow M. Breast cancer. Making the diagnosis. Surg Clin North Am 1999; 9: 991-1005.
14. Velez N, Earnest D, Staren E. Diagnostic and interventional ultrasound for breast disease. Am J Surg 2000; 180: 284-287.
15. Tanaka K, Shoji T, Tominaga Y, et al. Statistical analysis of diagnostic failure of fine needle aspiration cytology (FNAC) in breast cancer. J Surg Oncol 2001; 76: 100-105.
16. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 357-362.
17. Taillefer R. The role of 99mTc-Sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 1999; 29: 16-40.
18. Sampalis F, Denis R, Picard D, et al. International prospective evaluation of scintimammography with technetium-99m sestamibi: interim results. Am J Surg 2001; 182: 399-403.
19. Goldenberg D, Nabi H. Breast cancer imaging with radiolabeled antibodies. Semin Nucl Med 1999; 29: 41-48.